Method for Isolating Dopamine Neurons and Pharmaceutical Composition for Parkinson's Disease
Summary
The EPO granted Patent EP3591039A1 to S-BIOMEDICS covering a method for isolating dopamine neurons and a pharmaceutical composition containing those neurons for treating Parkinson's disease. The patent, with inventors KIM Dong-Wook, YOO Jeong-Eun, LEE Dongjin, PARK Sanghyun, KIM Jongwan, and CHO Myung Soo, designates 44 European states. The invention is classified under IPC categories for cell culture (C12N 5/0793), CNS-active pharmaceutical compositions (A61K 35/30), and anti-Parkinson agents (A61P 25/16).
What changed
The EPO published EP3591039A1, granting S-BIOMEDICS exclusive rights to a method for isolating dopamine neurons and a pharmaceutical composition containing those isolated neurons for treating Parkinson's disease. The patent covers cell culture techniques (C12N 5/0793), CNS pharmaceutical compositions (A61K 35/30), and anti-Parkinson therapeutic applications (A61P 25/16) across 44 designated European contracting states.
Pharmaceutical and biotechnology companies developing cell-based Parkinson's therapies in Europe must account for this patent when designing research programs or commercial products. Competitors may need to pursue licensing arrangements with S-BIOMEDICS or develop non-infringing alternative methods. The patent provides 20-year protection from the filing date, with national phase deadlines varying by designated state.
What to do next
- Monitor for national phase entry deadlines in designated states
- Evaluate freedom-to-operate implications in EU markets
- Review licensing opportunities from S-BIOMEDICS
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD FOR ISOLATING DOPAMINE NEURONS AND PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE, CONTAINING DOPAMINE NEURONS ISOLATED USING SAME
Publication EP3591039A1 Kind: A1 Apr 01, 2026
Applicants
S-BIOMEDICS
Inventors
KIM, Dong-Wook, YOO, Jeong-Eun, LEE, Dongjin, PARK, Sanghyun, KIM, Jongwan, CHO, Myung Soo
IPC Classifications
C12N 5/0793 20100101AFI20200505BHEP A61K 35/30 20150101ALI20200505BHEP A61P 25/16 20060101ALI20200505BHEP C12N 5/00 20060101ALI20200505BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.